MedPath

贵州远程制药有限责任公司

Ownership
-
Established
1998-05-05
Employees
-
Market Cap
-
Website
http://www.gzyczy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

NMPA:26

Drug Approvals

筋骨伤喷雾剂

Approval Number
国药准字Z20025387
Approval Date
May 30, 2024
NMPA

双冬胶囊

Approval Number
国药准字Z20120030
Approval Date
May 6, 2022
NMPA

八正颗粒

Approval Number
国药准字Z20060102
Approval Date
Jun 23, 2020
NMPA

癃清胶囊

Approval Number
国药准字Z20060246
Approval Date
Apr 27, 2020
NMPA

牛黄解毒片

Approval Number
国药准字Z52020020
Approval Date
Nov 18, 2019
NMPA

双黄消炎片

Approval Number
国药准字Z52020022
Approval Date
Nov 18, 2019
NMPA

维C银翘片

Approval Number
国药准字Z52020508
Approval Date
Nov 18, 2019
NMPA

Compound Paracetamol and Amantadine Hydrochloride Tablets

Product Name
复方氨酚烷胺片
Approval Number
国药准字H52020845
Approval Date
Nov 15, 2019
NMPA

Oxytetracycline Hydrochloride Tablets

Product Name
盐酸土霉素片
Approval Number
国药准字H52020049
Approval Date
Nov 15, 2019
NMPA

益肾兴阳胶囊

Approval Number
国药准字Z52020029
Approval Date
Oct 22, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.